Merlin differentially associates with the microtubule and actin cytoskeleton

Journal of Neuroscience Research

Volumn 51, Issue 3, 1998, Pages 403-415

  Xu, Hua Mei ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Actin; Neurofibromatosis 2; Schwannoma; Schwannomin; Tubulin

Indexed keywords

ACTIN; CELL SURFACE PROTEIN; COMPLEMENTARY DNA; MERLIN; TUBULIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CYTOSKELETON; GENE MUTATION; MICROTUBULE; NEURILEMOMA; NEUROFIBROMATOSIS; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; RABBIT; SKELETAL MUSCLE; TUMOR SUPPRESSOR GENE;

ACTINS; BINDING SITES; BIOPOLYMERS; CYTOSKELETON; GENES, NEUROFIBROMATOSIS 2; MEMBRANE PROTEINS; MICROTUBULES; NEUROFIBROMIN 2; PROTEIN CONFORMATION;

EID: 0032005305     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7     Document Type: Article

References (38)

1. Algrain M, Turunen O, Vaheri A, Louvard D, Arpin M (1993): Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol 120:129-139.
2. Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K (1997): Formation of actin stress fiber and focal adhesions enhanced by Rho-kinase. Science 275:1308-1311.
3. Andreoli C, Martin M, Le Borgne R, Reggio H, Mangeat P (1994): Ezrin has properties to self-associate at the plasma membrane. J Cell Sci 107:2509-2521.
4. Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJP, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR, Kley N (1994): Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumor types. Nature Genet 6:185-192.
5. den Bakker MA, Riegman PHJ, Hekman RACP, Coersma W, Janssen PJA, van der Kwast TH, Zwarthoff EC (1995): The product of the NF2 tumour suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells. Oncogene 10:757-763.
6. denBakker MA, Tacilar M, Reigman PHJ, Hekman ACP, Boersma W, Janssen PJA, deJong TAW, Hendriks Q, vanderKwast TH, Zwanoff E (1995): Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am J Pathol 147:1339-1349.
7. Evans DGR, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992): A clinical study of type 2 neurofibromatosis. Quart J Med 304:603-618.
8. Gary R, Bretscher A (1993): Heterotypic and homotypic associations between ezrin and moesin, two putative membrane-cytoskeletal linking proteins. Proc Natl Acad Sci USA 90:10846-10850.
9. Gary R, Bretscher A (1995): Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site. Mol Biol Cell 6:1061-1075.
10. Gonzalez-Agosti C, Xu L, Pinney D, Beauchamp R, Hobbs W, Gusella J, Ramesh V (1996): The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene 13:1239-1247.
11. Gould KL, Bretscher A, Esch FS, Hunter T (1989): cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1. EMBO J 8:4133-4142.
12. Gregory PE, Gutmann DH, Boguski M, Mitchell AM, Parks S, Jacks T, Wood DL, Jove R, Collins FS (1993): The neurofibromatosis type 1 gene product, neurofibromin, associates with microtubules. Somatic Cell Mol Genet 19:265-274.
13. Gulmann DH, Giordano MJ, Fishback AS, Guha A (1997): Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 48:267-270.
14. Gutmann DH, Geist RT, Xu HM, Kim JS, Saporito-Irwin S (in press): Defects in neurofibromatosis 2 protein function can arise at multiple levels. Human Mol Genet.
15. Henry MD, Agosti CG, Solomon F (1995): Molecular dissection of radixin: Distinct and interdependent functions of the amino- and carboxy-terminal domains. J Cell Biol 129:1007-1022.
16. Hirao M, Sato N, Kondo T, Yonemura S, Monden M, Sasaki T, Takai Y, Tsukita S, Tsukita S (1996): Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: Possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 135:37-51.
17. Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF (1996): Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer 17:45-55.
18. Lankes WT, Furthmayr H (1991): Moesin: A member of the protein 4.1-talin-ezrin family of proteins. Proc Natl Acad Sci USA 88:8297-8301.
19. Lankes WT, Schwartz-Albiez R, Furthmayr H (1993): Cloning and sequencing of porcine moesin and radixin cDNA and identification of highly conserved domains. Biochimica et Biophysica ACTA 1226:479-482.
20. Magendantz M, Henry MD, Lander A, Solomon F (1995): Interdomain interactions of radixin in vitro. J Biol Chem 270:25324-25327.
21. Martin M, Roy C, Montcourrier P, Sahuquet A, Mangeat P (1997): Three determinants in ezrin are responsible for cell extension activity. J Cell Biol 8:1543-1557.
22. Martuza RL, Eldridge R (1988): Neurofibromatosis 2 (Bilateral Acoustic Neurofibromatosis). New Engl J Med 318:685-688.
23. Mautner V-F, Lindenau M, Baser ME, Hazim W, Tagagiba M, Haase W, Samii M, Wais R, Pulst S-M (1996): The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 38:880-886.
24. Merel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijisma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, Delattre JY, Poisson M, Theillet C, Hulsebos T, Delattre O, Thomas G (1995): Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosomes Cancer 13:211-216.
25. Roy C, Martin M, Mangeat P (1997): A dual involvement of the amino-terminal domain of ezrin in F- and G-actin binding. J Biol Chem 272:20088-20095.
26. Ridley AJ, Hall A (1992): The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399.
27. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk M, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijisma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldrige R, Aurias A, Delattre O, Thomas G (1993): Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521.
28. Ruttledge MH, Andermann AA, Phelan CM, Claudio JO, Han F-y, Chretien N, Rangaratnam S, MacCollin M, Short P, Parry D, Michels V, Riccardi VM, Weksberg R, Kitamura K, Bradburn JM, Hall BD, Propping P, Rouleau GA (1996): Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Human Genet 59:331-342.
29. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM (1994): Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Human Mol Genet 3:885-891.
30. Scherer SS, Gutmann DH (1996): Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J Neurosci Res 46:595-605.
31. Scoles DR, Huynh DP, Coulsell ER, Robinson NGG, Tamanoi F, Pulst S-M (1996): The neurofibromatosis 2 gene product schwannomin interacts with beta-II-spectrin. Am J Human Genet 59:A5.
32. Sherman L, Xu H-M, Geist RT, Saporito-Irwin S, Howells N, Ponta H, Herrlich P, Gutmann DH (1997): Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene 15:2505-2509.
33. Takaishi K, Sasaki T, Kameyama T, Tsukita S, Tsukita S, Takai Y (1995): Translocation of activated RhoA from the cytoplasm to membrane ruffling area, cell-cell adhesion sites and cleavage furrows. Oncogene 11:39-48.
34. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Klay N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF (1993): A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:1-20.
35. Tsukita S, Heida Y, Tsukita S (1989): A new 82 kD barbed end-capping protein (radixin) localized in the cell-to-cell adherens junction: Purification and characterization. J Cell Biol 108:2369-2382.
36. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S (1994): ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126:391-401.
37. Twist EC, Ruttledge MH, Rouseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA (1994): The neurofibromatosis type 2 gene is inactivated in schwannomas. Human Mol Genet 3:147-151.
38. Xu H-M, Gutmann DH (1997): Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules. Brain Res 759:149-152.